Whistleblowers are Key to Reining in Prescription Drug Costs
The Mallinckrodt case spotlights what some drug companies might be doing to avoid this Medicaid pricing proscription.
Expand this whistleblower program to stop Putin’s cronies from evading sanctions
The new program is far more robust than its predecessor program, given it financially incentivizes the insider with a percentage of what the government recovers.
The Success of State Level False Claims Act Legislation Highlights Fraud Enforcement Victories
State False Claims Act laws permit states to pursue all types of frauds, including those related to any state contract.
With Infrastructure Investments, Whistleblowers Needed to Combat Potential Wage Theft
A recent study found that contractors who flout prevailing wage laws often continue to obtain government contracts.
Big Infrastructure Investments Could Prove Costly to Taxpayers, Lucrative to Fraudsters
Whistleblowers have a long history of reporting and prosecuting all types of infrastructure fraud through the False Claims Act.
New DOJ Statistics Spotlight the Role of Whistleblowers in Exposing Pandemic Health Care Fraud
Over 58% of all actual recoveries—amounting to $1.6 billion—came from whistleblower-initiated, or qui tam, actions.
Like the Omicron Variant, COVID-19 Fraud Continues to Run Rampant
As we approach the third year of the COVID-19 pandemic, it’s about time we check in on the fraud against the government relief programs.
The Whistleblower Interview: What do you need to know?
If you are a whistleblower who has filed a case under the False Claims Act, this is your moment.
How Telehealth Became a Big Target for Fraudsters
Prior to the pandemic, Medicare imposed strict limitations on when telehealth services were covered.
Pharmaceutical Company Payments to Co-Pay Foundations Merit Continued Scrutiny
Employees of pharmaceutical companies and co-pay foundations are particularly well-situated to observe and identify behavior that is not purely charitable.
